For research use only. Not for therapeutic Use.
Clemizole hydrochloride (Cat No.:I000589) is a pharmaceutical compound that acts as an antihistamine and a modulator of ion channels. It was initially developed as an antihistamine, primarily targeting the H1 histamine receptor. By blocking the H1 receptor, clemizole hydrochloride inhibits the effects of histamine, such as allergic reactions and itching. However, it has also been found to modulate other ion channels, including TRPC5 and TPRM7. These ion channels play roles in various physiological processes, including neuronal signaling and sensory perception. The modulation of ion channels by clemizole hydrochloride may contribute to its potential therapeutic applications beyond its antihistamine effects.
Catalog Number | I000589 |
CAS Number | 1163-36-6 |
Synonyms | AL 20;Allercur |
Molecular Formula | C19H20ClN3 • HCl |
Purity | ≥95% |
Target | H1 receptor; Anti-HCV |
Solubility | DMSO: ≥ 3.6 mg/mL |
Storage | -20°C |
Overview of Clinical Research | <span style=”color:#000000;”><span style=”font-size:12px;”><span style=”font-family:arial,helvetica,sans-serif;”>Clemizole is a Hepatitis C virus NS4 protein inhibitor. The Phase-II for Liver cancer discontinued in Turkey (PO) (Eiger BioPharmaceuticals pipeline, September 2020)</span></span></span> |
IC50 | 8mM (NS4B) |
IUPAC Name | 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole;hydrochloride |
InChI | InChI=1S/C19H20ClN3.ClH/c20-16-9-7-15(8-10-16)13-23-18-6-2-1-5-17(18)21-19(23)14-22-11-3-4-12-22;/h1-2,5-10H,3-4,11-14H2;1H |
InChIKey | DNFMJYXRIMLMBZ-UHFFFAOYSA-N |
SMILES | C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl.Cl |
Reference | <p style=”/line-height:25px/”> |